[ad_1]
NEW YORK, Oct. 12, 2022 /PRNewswire/ — The point-of-care (POC) diagnostics market size is set to grow by USD 13.09 billion from 2021 to 2026, according to Technavio. In addition, the growth momentum of the market will accelerate at a CAGR of 10.41% during the forecast period. The growing geriatric population is notably driving the POC diagnostics market growth. However, factors such as product recalls may challenge market growth.
Get a comprehensive report summary that describes the market size and forecast along with research methodology. The FREE sample report is available in PDF format
- Product
- Hematology Diagnostics
- Infectious Disease Diagnostics
- Rapid Cardiovascular Diagnostics
- Rapid Coagulation Diagnostics
- Others
- End-user
- Hospitals And Clinics
- Homecare Settings
- Clinical Diagnostic Laboratories
- Geography
- North America
- Europe
- Asia
- Rest Of The World (ROW)
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
The hematology diagnostics segment will be the largest contributor to market growth during the forecast period. The high incidence rates of thalassemia and anemia are driving the demand for hematology diagnostic products. Blood-related diseases such as hemophilia, thalassemia, and leukemia are highly prevalent in North America. Such diseases can be treated by prescribing blood transfusion and chelation therapy.
To help businesses improve their market position, the POC diagnostics market provides a detailed analysis of around 25 vendors operating in the market. Some of these vendors include Abaxis Inc, Abbott Laboratories, altona Diagnostics GmbH, Becton Dickinson and Co., bioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson, Meridian Bioscience Inc., Nova Biomedical Corp., PerkinElmer Inc., PTS Diagnostics, QIAGEN NV, Sekisui Chemical Co. Ltd., Siemens AG, Trinity Biotech Plc, and Trivida Health Inc. The key offerings of some of these vendors are listed below:
- Abbott Laboratories – The company offers POC diagnostic solutions with simple step-by-step instructions using a nasal swab and can be used for all ages.
- Becton Dickinson and Co. – The company offers POC diagnostic solutions for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
- Danaher Corp. – The company offers POC diagnostic solutions for glucose, urine albumin, and HbA1c as well as total and differential white blood cell count.
- F. Hoffmann La Roche Ltd. – The company offers POC diagnostic solutions to help both healthcare professionals and patients achieve improved clinical and health-economic outcomes by delivering robust, connected immediate results.
- PerkinElmer Inc. – The company offers POC diagnostic solutions for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens.
Get lifetime access to our Technavio Insights. Subscribe now to our most popular “Basic Plan” billed annually at USD 5000. View 100 reports and download 5 reports monthly!
- CAGR of the market during the forecast period 2022-2026
- Detailed information on factors that will help the POC diagnostics market grow during the next five years
- Estimation of the POC diagnostics market size and its contribution to the parent market
- Forecasts on upcoming trends and changes in consumer behavior
- The growth of the POC diagnostics market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of POC diagnostics market vendors
Pharmacogenomics Market by End-user and Geography – Forecast and Analysis 2022-2026: The pharmacogenomics market share is expected to increase by USD 2.50 billion from 2021 to 2026.
Heart Attack Diagnostics Market by End-User and Geography – Forecast and Analysis 2022-2026: The heart attack diagnostics market share is expected to increase by USD 5.34 billion from 2021 to 2026.
|
Point Of Care Diagnostics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 10.41% |
|
Market growth 2022-2026 |
USD 13.09 billion |
|
Market structure |
Fragmented |
|
YoY growth (%) |
10.19 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key consumer countries |
US, Canada, Germany, UK, Japan, and China |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement… |
Full story available on Benzinga.com
[ad_2]
Source link
